Skip to content

Dex-Cell Hysteroscopy Fluid Delivery Device

by Dexide, Inc. 510(k)

Active United States

510(k) K892001

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK892001 Date16 Jun 1989ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
HIG
Device Class
Class II
Regulation
21 CFR Part 884.1700
Advisory Committee
Obstetrics/Gynecology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This is an insufflator, hysteroscopic device used for fluid delivery during hysteroscopy procedures. It is classified as a Class II medical device under FDA regulation number 884.1700.

The device received FDA 510(k) clearance (K892001) on June 16, 1989, and is manufactured by Dexide, Inc. It is supplied as a reusable or single-use system depending on configuration, intended for use in obstetrics and gynecology clinical settings.

Other devices from Dexide, Inc.

See all devices from Dexide, Inc. →

Questions

AI-generated answers, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the DEX-CELL hysteroscopy fluid delivery device used for?

    The DEX-CELL hysteroscopy fluid delivery device is an insufflator used for fluid delivery during hysteroscopy procedures, as it is classified under FDA regulation number 884.1700 for hysteroscopic insufflators intended to distend the uterine cavity with fluid for visualization.

  • How is the DEX-CELL hysteroscopy fluid delivery device supplied?

    The DEX-CELL hysteroscopy fluid delivery device is supplied as a reusable or single-use system depending on configuration, allowing flexibility for clinical settings based on infection control protocols and facility preferences for reprocessing or disposal.

  • What regulatory pathway was used for the DEX-CELL hysteroscopy fluid delivery device?

    The DEX-CELL hysteroscopy fluid delivery device received FDA 510(k) clearance (K892001) on June 16, 1989, through a traditional submission demonstrating substantial equivalence to a legally marketed predicate device under Class II regulations for hysteroscopic insufflators.